111 related articles for article (PubMed ID: 10519928)
1. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis.
Kyd J; John A; Cripps A; Murphy TF
Vaccine; 1999 Oct; 18(5-6):398-406. PubMed ID: 10519928
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.
Murphy TF; Kyd JM; John A; Kirkham C; Cripps AW
J Infect Dis; 1998 Dec; 178(6):1667-75. PubMed ID: 9815219
[TBL] [Abstract][Full Text] [Related]
3. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model.
Hou Y; Hu WG; Hirano T; Gu XX
Vaccine; 2002 May; 20(17-18):2375-81. PubMed ID: 12009294
[TBL] [Abstract][Full Text] [Related]
4. [Detection of LOS-specific antibody-secreting cells by ELISPOT assay].
Jiao XA; Hirano T; Gu XX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):366-9. PubMed ID: 15193241
[TBL] [Abstract][Full Text] [Related]
5. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
Jiao X; Hirano T; Hou Y; Gu XX
Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.
Yassin GM; Amin MA; Attia AS
J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S
Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651
[TBL] [Abstract][Full Text] [Related]
8. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
9. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
Cripps AW; Dunkley ML; Clancy RL
Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunisation with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model.
Jomaa M; Kyd JM; Cripps AW
FEMS Immunol Med Microbiol; 2005 Apr; 44(1):59-67. PubMed ID: 15780579
[TBL] [Abstract][Full Text] [Related]
11. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model.
Maciver I; Unhanand M; McCracken GH; Hansen EJ
J Infect Dis; 1993 Aug; 168(2):469-72. PubMed ID: 8335988
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.
Forsgren A; Brant M; Riesbeck K
J Infect Dis; 2004 Jul; 190(2):352-5. PubMed ID: 15216472
[TBL] [Abstract][Full Text] [Related]
13. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.
Thomas LD; Dunkley ML; Moore R; Reynolds S; Bastin DA; Kyd JM; Cripps AW
Vaccine; 2000 Sep; 19(2-3):348-57. PubMed ID: 10930690
[TBL] [Abstract][Full Text] [Related]
14. Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance.
Kyd JM; Cripps AW; Murphy TF
J Med Microbiol; 1998 Feb; 47(2):159-68. PubMed ID: 9879959
[TBL] [Abstract][Full Text] [Related]
15. An aerosol challenge mouse model for Moraxella catarrhalis.
Hu WG; Chen J; Collins FM; Gu XX
Vaccine; 1999 Dec; 18(9-10):799-804. PubMed ID: 10580192
[TBL] [Abstract][Full Text] [Related]
16. Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.
Murphy TF; Kirkham C; Johnson A; Brauer AL; Koszelak-Rosenblum M; Malkowski MG
Vaccine; 2016 Jul; 34(33):3855-61. PubMed ID: 27265455
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
Hu WG; Berry J; Chen J; Gu XX
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
[TBL] [Abstract][Full Text] [Related]
18. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
Adlowitz DG; Kirkham C; Sethi S; Murphy TF
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
[TBL] [Abstract][Full Text] [Related]
19. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
[TBL] [Abstract][Full Text] [Related]
20. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.
Murphy TF; Brauer AL; Aebi C; Sethi S
Infect Immun; 2005 Dec; 73(12):8161-6. PubMed ID: 16299311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
